NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
Avon Products, Inc. (NYSE: AVP)
Class Period: August 2, 2016 to August 2, 2017
Lead Plaintiff Deadline: April 15, 2019
In order to inflate its reported revenue and representative growth metric during the Class Period, Avon engaged
in an undisclosed scheme whereby it significantly loosened its credit terms in order to recruit new representatives in Brazil, its
largest market. Avon did not disclose the changes to its credit terms in Brazil. Avon also failed to increase its allowance for
doubtful accounts to account for the changes to its credit terms in Brazil.
Get additional information about the AVP lawsuit: http://www.kleinstocklaw.com/pslra-1/avon-products-inc-loss-submission-form?wire=3
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
Class Period: November 4, 2015 to February 11, 2019
Lead Plaintiff Deadline: April 26, 2019
The lawsuit alleges that throughout the class period, Vanda Pharmaceuticals Inc. made materially false and/or
misleading statements and/or failed to disclose that: (1) Vanda was engaged in a fraudulent scheme in which it promoted the
off-label use of Fanapt and Hetlioz; (2) Vanda was fraudulently receiving drug reimbursements from the government by abusing
Medicare, Medicaid, and Tricare programs; (3) as a result of the scheme, Vanda faced legal action from the government; (4) Vanda’s
promotional materials for Fanapt and Hetlioz were false and misleading, garnering regulatory scrutiny from the U.S. Food and Drug
Administration; and (5) as a result, defendants’ statements about Vanda’s business, operations and prospects were materially false
and misleading and/or lacked a reasonable basis at all relevant times.
Get additional information about the VNDA lawsuit: http://www.kleinstocklaw.com/pslra-1/vanda-pharmaceuticals-inc-loss-submission-form?wire=3
CVS Health Corporation (NYSE: CVS)
Class Period: May 21, 2015 to February 20, 2019
Lead Plaintiff Deadline: April 26, 2019
The complaint alleges that throughout the class period CVS Health Corporation made materially false and/or
misleading statements and/or failed to disclose that: (i) CVS Health’s financial condition and expected earnings were deteriorating
as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health’s public
statements were materially false and misleading at all relevant times.
Get additional information about the CVS lawsuit: http://www.kleinstocklaw.com/pslra-1/cvs-health-corporation-loss-submission-form?wire=3
Inogen, Inc. (NASDAQGS: INGN)
Class Period: November 8, 2017 to February 26, 2019
Lead Plaintiff Deadline: May 6, 2019
The lawsuit alleges that Inogen, Inc. made materially false and/or misleading statements and/or failed to
disclose that: (i) Inogen had overstated the true size of the total addressable market (“TAM”) for its portable oxygen
concentrators and had misstated the basis for its calculation of the TAM; (ii) Inogen had falsely attributed its sales growth to
the strong sales acumen of its salesforce, when in reality it was due in large part to sales tactics designed to deceive its
elderly customer base; (iii) the growth in Inogen’s domestic business-to-business sales to home medical equipment (“HME”) providers
was inflated, unsustainable and was eroding direct-to-consumer sales; and (iv) very little of Inogen’s business was actually coming
from the more stable Medicare market.
Get additional information about the INGN lawsuit: http://www.kleinstocklaw.com/pslra-1/inogen-inc-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J.
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
